Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹18.64Admitted-Finance | ₹18.64 | L1 | Admitted-Finance |
| 2 | L2₹29.40Admitted-Finance | ₹29.40 | L2 | Admitted-Finance |
| 3 | L3₹93.50Admitted-Finance | ₹93.50 | L3 | Admitted-Finance |
| 4 | L4₹126.79Admitted-Finance S 2 GROUND FLOOR OKHLA INDUSTRIAL AREA PHASE II NEW DELHI DELHI 110020 UDYAM DL 09 0021388 04AARCM6226E1ZH B 07AARCM6226E1ZB R 19AARCM6226E1Z6 B 27AARCM6226E1Z9 B 09AARCM6226E1Z7 B | SOUTH EAST DELHI | DELHI | 110020 | ₹126.79 | L4 | Admitted-Finance |
| 5 | L5₹136.19Admitted-Finance | ₹136.19 | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | CONCEPT BIOMEDICAL L12 | SMPL Life Sciences Pvt. Ltd. L7 | MAA AMBEY ENTERPRISES L3 | GOYAL PHARMACEUTICALS L6 | SUPREME INTERNATIONAL PHARMACEUTICALS L11 | MASTODON BIOTECH L2 | RICH SURGICAL INDIA PRIVATE LIMITED L5 | Medikon India Private Limited L4 | AKSHAT PHARMA PRIVATE LIMITED L13 | ARECHAR HEALTHCARE LLP L8 | DDK Healthcare L10 | SAZ ENTERPRISES L9 | M/S NEW WAVES L1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00Dept of Chemo Day Centre | ||||||||||||||||
| 1.01 | Gefitinib 250mg Tab | 900 | No | 16.3 ₹17.12 | 11.27 ₹11.83 | - | - | 18 ₹18.90 | - | 18.7 ₹19.63 | - | 24 ₹25.20 | - | 16.1 ₹16.91 | 19.5 ₹20.48 | 17.75 ₹18.64 |
| 2.01 | Tab Lenvatinib 10mg | 1,000 | No | 52.8 ₹55.44 | 34.5 ₹36.23 | 36.6 ₹38.43 | 66.6 ₹69.93 | 49 ₹51.45 | - | - | - | 65 ₹68.25 | 66 ₹69.30 | 56 ₹58.80 | 65 ₹68.25 | - |
| 3.01 | Tab Lenvatinib 4mg | 1,500 | No | 26.4 ₹27.72 | 19.17 ₹20.13 | 24.4 ₹25.62 | 28.8 ₹30.24 | 33.5 ₹35.17 | 28 ₹29.40 | 33 ₹34.65 | - | 45 ₹47.25 | 30 ₹31.50 | 39.2 ₹41.16 | 31 ₹32.55 | - |
| 4.01 | Sunitinib 25 mg Tab | 392 | No | 26.71 ₹28.05 | 17.29 ₹18.15 | 28.05 ₹29.45 | - | 42 ₹44.10 | - | - | - | 24 ₹25.20 | 66 ₹69.30 | 27.6 ₹28.98 | 21.5 ₹22.57 | - |
| 5.01 | Erlotinib 100mg tab | 360 | No | 20.4 ₹21.42 | 32.4 ₹34.02 | - | - | - | - | - | - | 45 ₹47.25 | - | - | 52 ₹54.60 | - |
| 6.01 | Zoledronic Acid 4mg powder for inj | 150 | VIAL | 99 ₹103.95 | 54 ₹56.70 | - | 54 ₹56.70 | 85 ₹89.25 | - | 78 ₹81.90 | 120.75 ₹126.79 | 88 ₹92.40 | 17.25 ₹18.11 | 80.5 ₹84.53 | - | - |
Tender Value
₹1.4 L
EMD Value
₹6,784
Closing Date
16 Mar 2026, 6:00 pmClosed
THE COMMANDANT ARMY HOSPITAL R AND R
THE COMMANDANT ARMY HOSPITAL R AND R DELHI CANTT
2433/MS/EXP/D 1080,290/31/Chemo Day Centre(Drugs)/CFA RE-59/2025-26 FOR AHRR
2026_ARMY_753854_1
2433/MS/EXP/D 1080,290/31/Chemo Day Centre(Drugs)/CFA RE-59/2025-26
Open Tender
Medical Equipments/Waste
ARMY HOSPITAL R AND R DELHI CANTT
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
₹6,784
Yes
15 Apr 2026
23 Feb 2026
17 Mar 2026
23 Feb 2026
16 Mar 2026
23 Feb 2026
23 Feb 2026 - 16 Mar 2026
Dept of Chemo Day Centre
Gefitinib 250mg Tab
Tab Lenvatinib 10mg
Tab Lenvatinib 4mg
Sunitinib 25 mg Tab
Erlotinib 100mg tab
Zoledronic Acid 4mg powder for inj
Please Enable Macros to View BoQ information
stage.html
html • 0.05 MB
technical_844364.pdf
techsummary_844364.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.58 MB
RFP.pdf
Tender Documents • 1.26 MB
BOQ_844364.xls
BOQ • 0.86 MB
Download all tender documents and submit your bid